ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C
ScripThe usual pattern of reporting positive clinical trial results or winning US Food and Drug Administration approval then launching a large follow-on public offering (FOPO) has become less common under
ScripWho: AbbVie/Calibr – Scripps Research Institute What: AbbVie and the institute’s drug discovery unit are building upon existing collaborations, giving the pharma option rights to new discovery targ
In VivoA beneficial effect of sponsorship by the largest companies in the pharma industry can be seen in the fates of novel agent applications that faced US FDA approval decisions in recent years: the applic